Cutler Group’s BioCardia BCDA Stock Holding History

Cutler Group’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-60	Closed	-$1K	–	4907
2022 Q2	$1K	Sell	60 -7	-10%	-$168	﹤0.01%	4500
2022 Q1	$2K	Buy	+67	New	+$1.99K	﹤0.01%	4618

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's BCDA Position: Q3 2022 in Review

Cutler Group sold out of BioCardia (BCDA) in Q3 2022, closing a stake of 60 shares — an estimated $1K sold.

Cutler Group first reported a position in BCDA in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 23 funds tracked by Wall St. Rank hold BCDA as of Q3 2022.

Cutler Group reported no remaining BioCardia position as of Q3 2022 after selling out during the quarter.
Cutler Group sold 60 BioCardia shares in Q3 2022, an estimated $1K.
Cutler Group first reported a position in BioCardia in Q1 2022 and held it in 2 quarters.
Cutler Group's BioCardia position peaked at $2K in Q1 2022.
23 funds tracked by Wall St. Rank held BioCardia as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.